3rd Quarter - Report
FOLEY HOAG LLP for CUBIST PHARMACEUTICALS
Firm
Client
Income
$54,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S.3187, Food and Drug Administration Safety and Innovation Act; Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| J KEVIN BRENNAN | — |
| PAUL KIM | — |
| NICK LITTLEFIELD | — |
| ROSS DAVID MARGULIES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.